{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:32:44Z","timestamp":1793194364675,"version":"4.5.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nanoscale Res Lett"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s11671-018-2638-7","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:07:58Z","timestamp":1533902878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management"],"prefix":"10.1186","volume":"13","author":[{"given":"Khwaja Salahuddin","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-5540","authenticated-orcid":false,"given":"Azamal","family":"Husen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Sartaj","family":"Sohrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mensur Osman","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"2638_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pneurobio.2017.07.003","volume":"157","author":"L Huang","year":"2017","unstructured":"Huang L, Hu J, Huang S, Wang B, Siaw-Debrah F, Nyanzu M, Zhang Y, Zhuge Q (2017) Nanomaterial applications for neurological diseases and central nervous system injury. Prog Neurobiol 157:29\u201348","journal-title":"Prog Neurobiol"},{"key":"2638_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-3155-12-16","volume":"12","author":"A Husen","year":"2014","unstructured":"Husen A, Siddiqi KS (2014a) Carbon and fullerene nanomaterials in plant system. J Nanobiotechnol 12:16","journal-title":"J Nanobiotechnol"},{"key":"2638_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1556-276X-9-229","volume":"9","author":"A Husen","year":"2014","unstructured":"Husen A, Siddiqi KS (2014b) Phytosynthesis of nanoparticles: concept, controversy and application. Nano Res Lett 9:229","journal-title":"Nano Res Lett"},{"key":"2638_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12951-014-0028-6","volume":"12","author":"A Husen","year":"2014","unstructured":"Husen A, Siddiqi KS (2014c) Plants and microbes assisted selenium nanoparticles: characterization and application. J Nanobiotechnol 12:28","journal-title":"J Nanobiotechnol"},{"key":"2638_CR5","first-page":"231","volume":"2","author":"H Sadegh","year":"2015","unstructured":"Sadegh H, Shahryari-ghoshekandi R (2015) Functionalization of carbon nanotubes and its application in nanomedicine: a review. Nanomed J 2:231\u2013248","journal-title":"Nanomed J"},{"key":"2638_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s11671-018-2532-3","volume":"13","author":"KS Siddiqi","year":"2018","unstructured":"Siddiqi KS, Rahman A, Tajuddin, Husen A (2018) Properties of zinc oxide nanoparticles and their activity against microbes. Nano Res Lett 13:141","journal-title":"Nano Res Lett"},{"key":"2638_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s11671-016-1311-2","volume":"11","author":"KS Siddiqi","year":"2016","unstructured":"Siddiqi KS, Husen A (2016a) Fabrication of metal nanoparticles from fungi and metal salts: scope and application. Nano Res Lett 11:98","journal-title":"Nano Res Lett"},{"key":"2638_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s11671-016-1580-9","volume":"11","author":"KS Siddiqi","year":"2016","unstructured":"Siddiqi KS, Husen A (2016b) Fabrication of metal and metal oxide nanoparticles by algae and their toxic effects. Nano Res Lett 11:363","journal-title":"Nano Res Lett"},{"key":"2638_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s11671-016-1607-2","volume":"11","author":"KS Siddiqi","year":"2016","unstructured":"Siddiqi KS, Husen A (2016c) Engineered gold nanoparticles and plant adaptation potential. Nano Res Lett 11:400","journal-title":"Nano Res Lett"},{"key":"2638_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s11671-016-1695-z","volume":"11","author":"KS Siddiqi","year":"2016","unstructured":"Siddiqi KS, Husen A (2016d) Green synthesis, characterization and uses of palladium\/platinum nanoparticles. Nano Res Lett 11:482","journal-title":"Nano Res Lett"},{"key":"2638_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s11671-016-1714-0","volume":"11","author":"KS Siddiqi","year":"2016","unstructured":"Siddiqi KS, Rahman A, Tajuddin, Husen A (2016) Biogenic fabrication of iron\/iron oxide nanoparticles and their application. Nano Res Lett 11:498","journal-title":"Nano Res Lett"},{"key":"2638_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s11671-017-1861-y","volume":"12","author":"KS Siddiqi","year":"2017","unstructured":"Siddiqi KS, Husen A (2017a) Plant response to engineered metal oxide nanoparticles. Nano Res Lett 12:92","journal-title":"Nano Res Lett"},{"key":"2638_CR13","unstructured":"Keller AA, Lazareva A (2013) Predicted releases of engineered nanomaterials: from global to regional to local. Environ. Sci Technol Lett 1:65\u201370"},{"key":"2638_CR14","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1021\/es204168d","volume":"46","author":"A Weir","year":"2012","unstructured":"Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N (2012) Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46:2242\u20132250","journal-title":"Environ Sci Technol"},{"key":"2638_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cis.2008.09.002","volume":"145","author":"VK Sharma","year":"2009","unstructured":"Sharma VK, Yngard RA, Lin Y (2009) Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interf Sci 145:83\u201396","journal-title":"Adv Colloid Interf Sci"},{"key":"2638_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1477-3155-9-30","volume":"9","author":"HH Lara","year":"2011","unstructured":"Lara HH, Garza-Trevi\u00f1o EH, Ixtepan-Turrent L, Singh DK (2011) Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnol 9:30","journal-title":"J Nanobiotechnol"},{"key":"2638_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jtemb.2016.11.012","volume":"40","author":"KS Siddiqi","year":"2017","unstructured":"Siddiqi KS, Husen A (2017b) Recent advances in plant-mediated engineered gold nanoparticles and their application in biological system. J Trace Elements Med Biol 40:10\u201323","journal-title":"J Trace Elements Med Biol"},{"key":"2638_CR18","doi-asserted-by":"crossref","unstructured":"Husen A (2017) Gold nanoparticles from plant system: synthesis, characterization and application. In: Nanoscience and Plant\u2013Soil SystemsVol. 48 (Eds. Ghorbanpourn M, Manika K, Varma A) Springer International Publishing AG, Gewerbestrasse 11, 6330 Cham, Switzerland, pp.455\u2013479","DOI":"10.1007\/978-3-319-46835-8_17"},{"key":"2638_CR19","doi-asserted-by":"publisher","unstructured":"Kora AJ, Rastogi L (2015) Green synthesis of palladium nanoparticles using gum ghatti (Anogeissus latifolia) and its application as an antioxidant and catalyst. Arab J Chem https:\/\/doi.org\/10.1016\/j.arabjc.2015.06.024","DOI":"10.1016\/j.arabjc.2015.06.024"},{"key":"2638_CR20","first-page":"19","volume":"9417874","author":"PP Komane","year":"2016","unstructured":"Komane PP, Choonara YE, du Toit LC, Kumar P, Kondiah PDP, Modi G, Pillay V (2016) Diagnosis and treatment of neurological and ischemic disorders employing carbon nanotube technology. J Nanomat 9417874:19","journal-title":"J Nanomat"},{"key":"2638_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","volume":"64","author":"HL Wong","year":"2012","unstructured":"Wong HL, Wu XY, Bendayan R (2012) Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev 64:686\u2013700","journal-title":"Adv Drug Deliv Rev"},{"key":"2638_CR22","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.2147\/IJN.S87148","volume":"10","author":"B Fonseca-Santos","year":"2015","unstructured":"Fonseca-Santos B, Gremi\u00e3o MPD, Chorilli M (2015) Nanotechnology-based drug delivery systems for the treatment of Alzheimer\u2019s disease. Int J Nanomedicine 10:4981\u20135003","journal-title":"Int J Nanomedicine"},{"key":"2638_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/0972-2327.169535","volume":"18","author":"A Paurush","year":"2015","unstructured":"Paurush A, Daniel GA (2015) Nanotechnology in neurology: genesis, current status, and future prospects. Ann Ind Acad Neurol 18:382\u2013386","journal-title":"Ann Ind Acad Neurol"},{"key":"2638_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature 360:672\u2013674","journal-title":"Nature"},{"key":"2638_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375:754\u2013760","journal-title":"Nature"},{"key":"2638_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376:775\u2013778","journal-title":"Nature"},{"key":"2638_CR27","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112\u20132117","journal-title":"Lancet"},{"key":"2638_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer\u2019s disease. Lancet 342:697\u2013699","journal-title":"Lancet"},{"key":"2638_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.neurobiolaging.2007.11.003","volume":"30","author":"A Barabash","year":"2009","unstructured":"Barabash A, Marcos A, Ancin I, Vazquez-Alvarez B, de Ugarte C, Gil P, Fernandez C, Encinas M, Lopez-Ibor JJ, Cabranes JA (2009) APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease. Neurobiol Aging 30:1254\u20131264","journal-title":"Neurobiol Aging"},{"key":"2638_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2009.05.002","volume":"88","author":"G Modi","year":"2009","unstructured":"Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D (2009) Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol 88:272\u2013285","journal-title":"Prog Neurobiol"},{"key":"2638_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","volume":"76","author":"R Anand","year":"2014","unstructured":"Anand R, Gill KD, Mahdi AA (2014) Therapeutics of Alzheimer\u2019s disease: past, present and future. Neuropharmacology 76:27\u201350","journal-title":"Neuropharmacology"},{"key":"2638_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fbioe.2016.00049","volume":"4","author":"D Hadavi","year":"2016","unstructured":"Hadavi D, Poot AA (2016) Biomaterials for the treatment of Alzheimer\u2019s disease. Front Bioeng Biotechnol 4:49","journal-title":"Front Bioeng Biotechnol"},{"key":"2638_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/wnan.1202","volume":"5","author":"R Yokel","year":"2013","unstructured":"Yokel R, Grulke E, Macphail R (2013) Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:346\u2013373","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"2638_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/17435390.2014.940404","volume":"9","author":"G Bachler","year":"2015","unstructured":"Bachler G, Von Goetz N, Hungerbuhler K (2015) Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles. Nanotoxicology 9:373\u2013380","journal-title":"Nanotoxicology"},{"key":"2638_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chemosphere.2017.01.063","volume":"173","author":"Q Hu","year":"2017","unstructured":"Hu Q, Guo F, Zhao F, Fu Z (2017) Effects of titanium dioxide nanoparticles exposure on parkinsonism in zebrafish larvae and PC12. Chemosphere 173:373\u2013379","journal-title":"Chemosphere"},{"key":"2638_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nnano.2017.133","volume":"12","author":"J Yoo","year":"2017","unstructured":"Yoo J, Lee E, Kim HY, Youn DH, Jung J, Kim H, Chang Y, Lee W, Shin J, Baek S, Jang W, Jun W, Kim S, Hong J, Park HJ, Lengner CJ, Moh SH, Kwon Y, Kim J (2017) Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson\u2019s disease therapy. Nat Nanotech 12:1006\u20131014","journal-title":"Nat Nanotech"},{"key":"2638_CR37","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.nano.2012.05.007","volume":"8","author":"F Re","year":"2012","unstructured":"Re F, Gregori M, Masserini M (2012) Nanotechnology for neurodegenerative disorders. Nanomed Nanotechnol Biol Med 8:S51\u2013S58","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"2638_CR38","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.2147\/IJN.S30919","volume":"7","author":"JR Kanwar","year":"2012","unstructured":"Kanwar JR, Sriramoju B, Kanwar RK (2012) Neurological disorders and therapeutics targeted to surmount the blood\u2013brain barrier. Int J Nanomedicine 7:3259\u20133278","journal-title":"Int J Nanomedicine"},{"key":"2638_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-015-0156-7","volume":"14","author":"E Sulheim","year":"2016","unstructured":"Sulheim E, Baghirov H, von Haartman E, B\u00f8e A, \u00c5slund AK, M\u00f8rch Y, Davies Cde L (2016) Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles. J Nanobiotechnol 14:1","journal-title":"J Nanobiotechnol"},{"key":"2638_CR40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/17425247.2016.1178237","volume":"13","author":"I Cacciatore","year":"2016","unstructured":"Cacciatore I, Ciulla M, Fornasari E, Marinelli L, Di Stefano A (2016) Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. Expert Opin Drug Deliv 13:1121\u20131131","journal-title":"Expert Opin Drug Deliv"},{"key":"2638_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","volume":"108","author":"C Roney","year":"2005","unstructured":"Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana NN, Manohar S, Liang HF, Kulkarni AR, Sung HW, Sairam M, Aminabhavi TM (2005) Targeted nanoparticles for delivery through blood brain barrier for Alzheimer\u2019s disease. J Cont Rel 108:193\u2013214","journal-title":"J Cont Rel"},{"key":"2638_CR42","doi-asserted-by":"publisher","unstructured":"Vashist A, Kaushik A, Vashist A, Bala J, Nikkhah-Moshaie R, Sagar V, Nair M (2018) Nanogels potential drug nanocarriers for CNS drug delivery. Drug Discov Today https:\/\/doi.org\/10.1016\/j.drudis.2018.05.018","DOI":"10.1016\/j.drudis.2018.05.018"},{"key":"2638_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jnr.23299","volume":"92","author":"W Zhang","year":"2014","unstructured":"Zhang W, Wang GM, Wang PJ, Zhang Q, Sha SH (2014b) Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer\u2019s disease. J Neurosci Res 92:185\u2013194","journal-title":"J Neurosci Res"},{"key":"2638_CR44","doi-asserted-by":"publisher","unstructured":"Zhang G, Khan AA, Wu H, Chen L, Gu Y, Gu N (2017) The application of nanomaterials in stem cell therapy for some neurological diseases. Curr Drug Targets. https:\/\/doi.org\/10.2174\/1389450118666170328115801","DOI":"10.2174\/1389450118666170328115801"},{"key":"2638_CR45","doi-asserted-by":"publisher","first-page":"40758","DOI":"10.1038\/srep40758","volume":"7","author":"J Trekker","year":"2017","unstructured":"Trekker J, Himmelreich U, Beiras A, Topete A, Taboada P, P\u00e9rez-Mato M, Vieites-Prado A, Iglesias-Rey R, Rivas J, Planas AM, Sobrino T, Castillo J, Campos F (2017) Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. Sci Rep 7:40758","journal-title":"Sci Rep"},{"key":"2638_CR46","first-page":"2","volume":"5","author":"PN Anna","year":"2015","unstructured":"Anna PN (2015) Nanotechnology and its applications in medicine. Med Chem 5:2","journal-title":"Med Chem"},{"key":"2638_CR47","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0306-4522(02)00697-8","volume":"118","author":"L Sun","year":"2003","unstructured":"Sun L, Liu SY, Zhou XW, Wang XC, Liu R, Wang Q, Wang JZ (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118:1175\u20131182","journal-title":"Neuroscience"},{"key":"2638_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1\u201313","journal-title":"Neurobiol Dis"},{"key":"2638_CR49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jconrel.2003.08.006","volume":"93","author":"PR Lockman","year":"2003","unstructured":"Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD (2003) Brain uptake of thiamine-coated nanoparticles. J Control Release 93:271\u2013282","journal-title":"J Control Release"},{"key":"2638_CR50","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","volume":"28","author":"A Beduneau","year":"2007","unstructured":"Beduneau A, Saulnier P, Benoit JP (2007) Active targeting of brain tumors using nanocarriers. Biomaterials 28:4947\u20134967","journal-title":"Biomaterials"},{"key":"2638_CR51","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2685","volume":"10","author":"G Orive","year":"2009","unstructured":"Orive G, Anitua E, Pedraz JL, Emerich DF (2009) Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 10:682\u2013692","journal-title":"Nat Rev Neurosci"},{"key":"2638_CR52","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1517\/13543784.13.12.1585","volume":"13","author":"CW Ritchie","year":"2004","unstructured":"Ritchie CW, Bush AI, Masters CL (2004) Metal-protein attenuating compounds and Alzheimer\u2019s disease. Expert Opin Invest Drug 13:1585\u20131592","journal-title":"Expert Opin Invest Drug"},{"key":"2638_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0304-3940(02)01399-X","volume":"338","author":"W Hartig","year":"2003","unstructured":"Hartig W, Paulke B, Varga C, Seeger J, Harkany T, Kacza J (2003) Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting h-amyloid in Alzheimer\u2019s disease. Neurosci Lett 338:174\u2013176","journal-title":"Neurosci Lett"},{"key":"2638_CR54","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 2:1403","journal-title":"Lancet"},{"key":"2638_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137\u2013147","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2638_CR56","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0091-3057(94)90267-4","volume":"49","author":"DJ Fontana","year":"1994","unstructured":"Fontana DJ, Inouye GT, Johnson RM (1994) Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neuro transmission. Pharmacol Biochem Behav 49:1075\u20131082","journal-title":"Pharmacol Biochem Behav"},{"key":"2638_CR57","doi-asserted-by":"crossref","unstructured":"Kurihara K, Ueda M, Hara I, Ozeki E, Togashi K, Kimura S (2018) Polymeric micelle of A B-type lactosome as a vehicle for targeting meningeal dissemination. Nanomaterials 8:79","DOI":"10.3390\/nano8020079"},{"key":"2638_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40139-016-0118-2","volume":"4","author":"C Fornaguera","year":"2016","unstructured":"Fornaguera C, Solans C (2016) Polymeric nanoparticles for drug delivery in neurological diseases. Curr Pathobiol Rep 4:189\u2013197","journal-title":"Curr Pathobiol Rep"},{"key":"2638_CR59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1517\/17425240902939143","volume":"6","author":"E Barbu","year":"2009","unstructured":"Barbu E, Moln\u00e0r E, Tsibouklis J, G\u00f3recki DC (2009) The potential for nanoparticle-based drug delivery to the brain: overcoming the blood\u2013brain barrier. Expert Opin Drug Deliv 6:553\u2013565","journal-title":"Expert Opin Drug Deliv"},{"key":"2638_CR60","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","volume":"452","author":"ZZ Yang","year":"2013","unstructured":"Yang ZZ, Zhang YQ, Wang ZZ, Wu K, Lou JN, Qi XR (2013) Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration. Int J Pharm 452:344\u2013354","journal-title":"Int J Pharm"},{"key":"2638_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejpb.2008.03.009","volume":"70","author":"B Wilson","year":"2008","unstructured":"Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B (2008) Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 70:75\u201384","journal-title":"Eur J Pharm Biopharm"},{"key":"2638_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","volume":"35","author":"C Zhang","year":"2014","unstructured":"Zhang C, Wan X, Zheng X, Shao X, Liu Q, Zhang Q, Qian Y (2014) Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice. Biomaterials 35:456\u2013465","journal-title":"Biomaterials"},{"key":"2638_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 158:47\u201352","journal-title":"J Neurol Sci"},{"key":"2638_CR64","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0891-5849(99)00016-7","volume":"26","author":"RJ Castellani","year":"1999","unstructured":"Castellani RJ, Smith MA, Nunomura A, Harris PL, Perry G (1999) Is increased redoxactive iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic Biol Med 26:1508\u20131512","journal-title":"Free Radic Biol Med"},{"key":"2638_CR65","doi-asserted-by":"publisher","first-page":"RC10","DOI":"10.1523\/JNEUROSCI.19-11-j0002.1999","volume":"19","author":"JY Lee","year":"1999","unstructured":"Lee JY, Mook-Jung I, Koh JY (1999) Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice. J Neurosci 19:RC10","journal-title":"J Neurosci"},{"key":"2638_CR66","doi-asserted-by":"publisher","first-page":"40302","DOI":"10.1074\/jbc.M206428200","volume":"277","author":"C Opazo","year":"2002","unstructured":"Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R, Masters CL, Tanzi RE, Inestrosa NC, Bush AI (2002) Metalloenzyme-like activity of Alzheimer\u2019s disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277:40302\u201340308","journal-title":"J Biol Chem"},{"key":"2638_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/psc.626","volume":"11","author":"FE Ali","year":"2005","unstructured":"Ali FE, Separovic F, Barrow CJ, Cherny RA, Fraser F, Bush AI, Masters CL, Barnham KJ (2005) Methionine regulates copper\/hydrogen peroxide oxidation products of Abeta. J Pept Sci 11:353\u2013360","journal-title":"J Pept Sci"},{"key":"2638_CR68","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1096\/fj.04-1890fje","volume":"18","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, Beyreuther K, Carrington D, Masters CL, Cherny RA, Cappai R, Bush AI (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer\u2019s disease beta-amyloid. FASEB J 18:1427\u20131429","journal-title":"FASEB J"},{"key":"2638_CR69","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1021\/jf0735073","volume":"56","author":"M Singh","year":"2008","unstructured":"Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C (2008) Challenges for research on polyphenols from foods in Alzheimer\u2019s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 56:4855\u20134873","journal-title":"J Agric Food Chem"},{"key":"2638_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0024-3205(01)01438-2","volume":"70","author":"YT Choi","year":"2001","unstructured":"Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, Suh MH, Park J, Park CW, Suh SI (2001) The green tea polyphenol (\u2212)-epigallocatechin gallate attenuates betaamyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70:603\u2013614","journal-title":"Life Sci"},{"key":"2638_CR71","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1096\/fj.02-0881fje","volume":"17","author":"Y Levites","year":"2003","unstructured":"Levites Y, Amit T, Mandel S, Youdim MB (2003) Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (\u2212)-epigallocatechin-3-gallate. FASEB J 17:952\u2013954","journal-title":"FASEB J"},{"key":"2638_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1460-9568.2005.04532.x","volume":"23","author":"S Bastianetto","year":"2006","unstructured":"Bastianetto S, Yao ZX, Papadopoulos V, Quirion R (2006) Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid induced toxicity. Eur J Neurosci 23:55\u201364","journal-title":"Eur J Neurosci"},{"key":"2638_CR73","doi-asserted-by":"publisher","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","volume":"285","author":"AR Ladiwala","year":"2010","unstructured":"Ladiwala AR, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, Tessier PM (2010) Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem 285:24228\u201324237","journal-title":"J Biol Chem"},{"key":"2638_CR74","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides. J Biol Chem 280:37377\u201337382","journal-title":"J Biol Chem"},{"key":"2638_CR75","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","volume":"141","author":"YS Han","year":"2004","unstructured":"Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R (2004) Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141:997\u20131005","journal-title":"Br J Pharmacol"},{"key":"2638_CR76","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jnutbio.2007.08.008","volume":"19","author":"AM Haque","year":"2008","unstructured":"Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O (2008) Green tea catechins prevent cognitive deficits caused by Abeta1\u201340 in rats. J Nutr Biochem 19:619\u2013626","journal-title":"J Nutr Biochem"},{"key":"2638_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000097511","volume":"79","author":"A Kumar","year":"2007","unstructured":"Kumar A, Naidu PS, Seghal N, Padi SSV (2007) Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79:17\u201326","journal-title":"Pharmacology"},{"key":"2638_CR78","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00394-015-0894-1","volume":"55","author":"C Regitz","year":"2016","unstructured":"Regitz C, Fitzenberger E, Mahn FL, Du\u00dfling LM, Wenzel U (2016) Resveratrol reduces amyloid-beta (A\u03b21\u201342)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. Eur J Nutr 55:741\u2013747","journal-title":"Eur J Nutr"},{"key":"2638_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","volume":"282","author":"H Wang","year":"2018","unstructured":"Wang H, Jiang T, Li W, Gao N, Zhang T (2018) Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease. Toxicol Lett 282:100\u2013108","journal-title":"Toxicol Lett"},{"key":"2638_CR80","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12640-017-9726-9","volume":"32","author":"H Yin","year":"2017","unstructured":"Yin H, Wang H, Zhang H, Gao N, Zhang T, Yang Z (2017) Resveratrol attenuates A\u03b2-induced early hippocampal neuron excitability impairment via recovery of function of potassium channels. Neurotox Res 32:311\u2013324","journal-title":"Neurotox Res"},{"key":"2638_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2010.08.035","volume":"485","author":"H Liu","year":"2010","unstructured":"Liu H, Li Z, Qiu D, Gu Q, Lei Q, Mao L (2010) The inhibitory effects of different curcuminoids on beta-amyloid protein, beta-amyloid precursor protein and beta-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells. Neurosci Lett 485:83\u201388","journal-title":"Neurosci Lett"},{"key":"2638_CR82","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"K Ono","year":"2004","unstructured":"Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent antiamyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro. J Neurosci Res 75:742\u2013750","journal-title":"J Neurosci Res"},{"key":"2638_CR83","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892\u20135901","journal-title":"J Biol Chem"},{"key":"2638_CR84","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095\u20131104","journal-title":"J Neurochem"},{"key":"2638_CR85","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","volume":"21","author":"GP Lim","year":"2001","unstructured":"Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370\u20138377","journal-title":"J Neurosci"},{"key":"2638_CR86","first-page":"993","volume":"22","author":"SA Frautschy","year":"2001","unstructured":"Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology, Neurobiol. Aging 22:993\u20131005","journal-title":"Aging"},{"key":"2638_CR87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0304-3940(01)01677-9","volume":"303","author":"DS Kim","year":"2001","unstructured":"Kim DS, Park SY, Kim JK (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1\u201342) insult. Neurosci Lett 303:57\u201361","journal-title":"Neurosci Lett"},{"key":"2638_CR88","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.euroneuro.2009.02.002","volume":"19","author":"T Ishrat","year":"2009","unstructured":"Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer\u2019s type (SDAT). Eur Neuropsychopharmacol 19:636\u2013647","journal-title":"Eur Neuropsychopharmacol"},{"key":"2638_CR89","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","volume":"25","author":"K Rezai-Zadeh","year":"2005","unstructured":"Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807\u20138814","journal-title":"J Neurosci"},{"key":"2638_CR90","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1016\/j.bmcl.2003.09.018","volume":"13","author":"SY Jeon","year":"2003","unstructured":"Jeon SY, Bae KH, Seong YH, Song KS (2003) Green tea catechins as a BACE1 (betasecretase) inhibitor. Bioorg Med Chem Lett 13:3905\u20133908","journal-title":"Bioorg Med Chem Lett"},{"key":"2638_CR91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558\u2013566","journal-title":"Nat Struct Mol Biol"},{"key":"2638_CR92","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A 107:7710\u20137715","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2638_CR93","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jnutbio.2006.11.001","volume":"18","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Jeong HJ, Lee KM, Myung NY, An NH, Yang WM, Park SK, Lee HJ, Hong SH, Kim HM, Um JY (2007) Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J Nutr Biochem 18:587\u2013596","journal-title":"J Nutr Biochem"},{"key":"2638_CR94","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JAD-2004-6403","volume":"6","author":"L Baum","year":"2004","unstructured":"Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J Alzheimers Dis 6:367\u20133778 discussion 443\u2013369","journal-title":"J Alzheimers Dis"},{"key":"2638_CR95","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807\u2013818","journal-title":"Mol Pharm"},{"key":"2638_CR96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","volume":"853","author":"KY Yang","year":"2007","unstructured":"Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853:183\u2013189","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2638_CR97","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0300-483X(81)90027-5","volume":"22","author":"V Ravindranath","year":"1981","unstructured":"Ravindranath V, Chandrasekhara N (1981) Metabolism of curcumin\u2014studies with [3H] curcumin. Toxicology 22:337\u2013344","journal-title":"Toxicology"},{"key":"2638_CR98","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/10611869609015962","volume":"3","author":"SI Rapoport","year":"1996","unstructured":"Rapoport SI (1996) Modulation of blood-brain barrier permeability. J Drug Target 3:417\u2013425","journal-title":"J Drug Target"},{"key":"2638_CR99","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1023\/A:1015884603456","volume":"8","author":"WA Banks","year":"1991","unstructured":"Banks WA, Kastin AJ, Barrera CM (1991) Delivering peptides to the central nervous system: dilemmas and strategies. Pharm Res 8:1345\u20131350","journal-title":"Pharm Res"},{"key":"2638_CR100","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.colsurfb.2008.07.004","volume":"66","author":"G Sonavane","year":"2008","unstructured":"Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Coll Surf B Biointerf 66:274\u2013280","journal-title":"Coll Surf B Biointerf"},{"key":"2638_CR101","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","volume":"24","author":"JD Huber","year":"2001","unstructured":"Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719\u2013725","journal-title":"Trends Neurosci"},{"key":"2638_CR102","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","volume":"17","author":"AH Faraji","year":"2009","unstructured":"Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17:2950\u20132962","journal-title":"Bioorg Med Chem"},{"key":"2638_CR103","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","volume":"152","author":"JK Sahni","year":"2011","unstructured":"Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C (2011) Neurotherapeutic applications of nanoparticles in Alzheimer\u2019s disease. J Cont Rel 152:208\u2013231","journal-title":"J Cont Rel"},{"key":"2638_CR104","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2217\/nnm.14.206","volume":"10","author":"M Gregori","year":"2015","unstructured":"Gregori M, Masserini M, Mancini S (2015) Nanomedicine for the treatment of Alzheimer\u2019s disease. Nanomedicine (Lond) 10:1203\u20131218","journal-title":"Nanomedicine (Lond)"},{"key":"2638_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","volume":"245","author":"MM Wen","year":"2017","unstructured":"Wen MM, El-Salamouni NS, El-Refaie WM, Hazzah HA, Ali MM, Tosi G, Farid RM, Blanco-Prieto MJ, Billa N, Hanafy AS (2017) Nanotechnology-based drug delivery systems for Alzheimer\u2019s disease management: technical, industrial, and clinical challenges. J Cont Rel 245:95\u2013107","journal-title":"J Cont Rel"},{"key":"2638_CR106","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286","journal-title":"Front Pharmacol"},{"key":"2638_CR107","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","volume":"23","author":"J Qu","year":"2016","unstructured":"Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, Zhu X, Zhu J (2016) Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Drug Deliv 23:3408\u20133416","journal-title":"Drug Deliv"},{"key":"2638_CR108","first-page":"29","volume":"5","author":"JS D\u2019Arrigo","year":"2017","unstructured":"D\u2019Arrigo JS (2017) Alzheimer\u2019s disease, brain injury, and C.N.S. nanotherapy in humans: sonoporation augmenting drug targeting. Med Sci 5:29","journal-title":"Med Sci"},{"key":"2638_CR109","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/DDDT.S99651","volume":"10","author":"TA Ahmed","year":"2016","unstructured":"Ahmed TA, Aljaeid BM (2016) Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther 10:483\u2013507","journal-title":"Drug Des Devel Ther"},{"key":"2638_CR110","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/1556-276X-9-538","volume":"9","author":"MA Busquets","year":"2014","unstructured":"Busquets MA, Sabat\u00e9 R, Estelrich J (2014) Potential applications of magnetic particles to detect and treat Alzheimer\u2019s disease. Nano Res Lett 9:538","journal-title":"Nano Res Lett"},{"key":"2638_CR111","doi-asserted-by":"publisher","first-page":"17261","DOI":"10.1038\/srep17261","volume":"5","author":"S Teller","year":"2015","unstructured":"Teller S, Tahirbegi IB, Mir M, Samitier J, Soriano J (2015) Magnetite-amyloid-\u03b2 deteriorates activity and functional organization in an in vitro model for Alzheimer\u2019s disease. Sci Rep 5:17261","journal-title":"Sci Rep"},{"key":"2638_CR112","doi-asserted-by":"publisher","first-page":"415702","DOI":"10.1088\/0957-4484\/27\/41\/415702","volume":"27","author":"YW Chen","year":"2016","unstructured":"Chen YW, Chang CW, Hung HS, Kung ML, Yeh BW, Hsieh S (2016) Magnetite nanoparticle interactions with insulin amyloid fibrils. Nanotechnology 27:415702","journal-title":"Nanotechnology"},{"key":"2638_CR113","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Cont Rel 235:34\u201347","journal-title":"J Cont Rel"},{"key":"2638_CR114","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","volume":"13","author":"M Karimi","year":"2016","unstructured":"Karimi M, Bahrami S, Ravari SB, Zangabad PS, Mirshekari H, Bozorgomid M, Shahreza S, Sori M, Hamblin MR (2016) Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Deliv 13:1609\u20131623","journal-title":"Expert Opin Drug Deliv"},{"key":"2638_CR115","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/chem.201404562","volume":"21","author":"N Gao","year":"2015","unstructured":"Gao N, Sun H, Dong K, Ren J, Qu X (2015) Gold-nanoparticle-based multifunctional amyloid-\u03b2 inhibitor against Alzheimer\u2019s disease. Chemistry 21:829\u2013835","journal-title":"Chemistry"},{"key":"2638_CR116","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fnins.2017.00082","volume":"11","author":"DK Sarko","year":"2017","unstructured":"Sarko DK, McKinney CE (2017) Exosomes: origins and therapeutic potential for neurodegenerative disease. Front Neurosci 11:82","journal-title":"Front Neurosci"},{"key":"2638_CR117","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbrc.2016.09.090","volume":"483","author":"C Quek","year":"2017","unstructured":"Quek C, Hill AF (2017) The role of extracellular vesicles in neurodegenerative diseases. Biochem Biophys Res Commun 483:1178\u20131186","journal-title":"Biochem Biophys Res Commun"},{"key":"2638_CR118","first-page":"7027380","volume":"2017","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zhao B, Zhao J, Li S (2017) Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer\u2019s disease. Neural Plast 2017:7027380","journal-title":"Neural Plast"},{"key":"2638_CR119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2017.02.038","volume":"521","author":"XC Jiang","year":"2017","unstructured":"Jiang XC, Gao JQ (2017) Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm 521:167\u2013175","journal-title":"Int J Pharm"},{"key":"2638_CR120","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.2174\/1381612821666150917094031","volume":"21","author":"M Sonmez","year":"2015","unstructured":"Sonmez M, Georgescu M, Alexandrescu L, Gurau D, Ficai A, Ficai D, Andronescu E (2015) Synthesis and applications of Fe3O4\/SiO2 core-shell materials. Curr Pharm Des 21:5324\u20135335","journal-title":"Curr Pharm Des"},{"key":"2638_CR121","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.nano.2014.03.015","volume":"10","author":"M Mizrahi","year":"2014","unstructured":"Mizrahi M, Friedman-Levi Y, Larush L, Frid K, Binyamin O, Dori D, Fainstein N, Ovadia H, Ben-Hur T, Magdassi S, Gabizon R (2014) Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD. Nanomedicine 10:1353\u20131363","journal-title":"Nanomedicine"},{"key":"2638_CR122","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/03639045.2011.625031","volume":"38","author":"J Shi","year":"2012","unstructured":"Shi J, Cong W, Wang Y, Liu Q, Luo G (2012) Microemulsion-based patch for transdermal delivery of huperzine a and ligustrazine phosphate in treatment of Alzheimer\u2019s disease. Drug Dev Ind Pharm 38:752\u2013761","journal-title":"Drug Dev Ind Pharm"},{"key":"2638_CR123","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1039\/C5NJ00309A","volume":"39","author":"W Tomasz","year":"2015","unstructured":"Tomasz W, Marcinkowska M, Pieszynski I, Zablocka M, Caminade AM, Majora JP, Klajnert-Maculewiczae B (2015) Cationic phosphorus dendrimers and therapy for Alzheimer\u2019s disease. New J Chem 39:4852","journal-title":"New J Chem"},{"key":"2638_CR124","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","volume":"43","author":"J Rogers","year":"1993","unstructured":"Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clinical trial of indomethacin in Alzheimer\u2019s disease. Neurology 43:1609\u20131611","journal-title":"Neurology"},{"key":"2638_CR125","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1212\/WNL.53.1.197","volume":"53","author":"S Scharf","year":"1999","unstructured":"Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N (1999) A double-blind, placebo controlled trial of diclofenac\/misoprostol in Alzheimer\u2019s disease. Neurology 53:197\u2013201","journal-title":"Neurology"},{"key":"2638_CR126","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","volume":"289","author":"PS Aisen","year":"2003","unstructured":"Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289:2819\u20132826","journal-title":"JAMA"},{"key":"2638_CR127","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"PA Adlard","year":"2008","unstructured":"Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59:43\u201355","journal-title":"Neuron"},{"key":"2638_CR128","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2009.03.064","volume":"455","author":"G Liu","year":"2009","unstructured":"Liu G, Men P, Kudo W, Perry G, Smith MA (2009) Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci Lett 455:187\u2013190","journal-title":"Neurosci Lett"},{"key":"2638_CR129","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30:665\u2013676","journal-title":"Neuron"},{"key":"2638_CR130","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.biomaterials.2010.10.027","volume":"32","author":"S Mourtas","year":"2011","unstructured":"Mourtas S, Canovi M, Zona C, Aurilia D, Niarakis A, La Ferla B, Salmona M, Nicotra F, Gobbi M, Antimisiaris SG (2011) Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1-42 peptide. Biomaterials 32:1635\u20131645","journal-title":"Biomaterials"},{"key":"2638_CR131","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","volume":"20","author":"MA Ansari","year":"2009","unstructured":"Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA (2009) Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer\u2019s disease. J Nutr Biochem 20:269\u2013275","journal-title":"J Nutr Biochem"},{"key":"2638_CR132","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbr.2006.03.043","volume":"171","author":"J Lu","year":"2006","unstructured":"Lu J, Zheng YL, Luo L, Wu DM, Sun DX, Feng YJ (2006) Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav Brain Res 171:251\u2013260","journal-title":"Behav Brain Res"},{"key":"2638_CR133","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3844\/ajassp.2010.480.485","volume":"7","author":"W Phachonpai","year":"2010","unstructured":"Phachonpai W, Wattanathorn J, Muchimapura S, Tong-Un T, Preechagoon D (2010) Neuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against Alzheimer\u2019s disease. Am J Appl Sci 7:480\u2013485","journal-title":"Am J Appl Sci"},{"key":"2638_CR134","doi-asserted-by":"publisher","first-page":"14439","DOI":"10.1002\/chem.201001654","volume":"16","author":"Y An","year":"2010","unstructured":"An Y, Tang L, Jiang X, Chen H, Yang M, Jin L, Zhang S, Wanf C, Zhnag W (2010) A photoelectrochemical immunosensor based on Au-doped TiO2 nanotube arrays for the detection of \u03b1-synuclein. Chemistry 16:14439\u201314446","journal-title":"Chemistry"},{"key":"2638_CR135","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.M805956200","volume":"284","author":"L Hasadsri","year":"2009","unstructured":"Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM (2009) Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem 284:6972\u20136981","journal-title":"J Biol Chem"},{"key":"2638_CR136","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2217\/nnm.13.115","volume":"9","author":"NL Klyachko","year":"2014","unstructured":"Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV (2014) Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine (Lond.) 9:403\u2013422","journal-title":"Nanomedicine (Lond.)"},{"key":"2638_CR137","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1172\/JCI33464","volume":"118","author":"AS Basso","year":"2008","unstructured":"Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL (2008) Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest 118:1532\u20131543","journal-title":"J Clin Invest"},{"issue":"Suppl 6","key":"2638_CR138","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00415-008-6001-2","volume":"255","author":"T Korn","year":"2008","unstructured":"Korn T (2008) Pathophysiology of multiple sclerosis. J Neurol 255(Suppl 6):2\u20136","journal-title":"J Neurol"},{"key":"2638_CR139","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijpharm.2011.05.062","volume":"415","author":"K Hu","year":"2011","unstructured":"Hu K, Shi Y, Jiang W, Han J, Huang S, Jiang X (2011) Lactoferrin conjugated PEGPLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson\u2019s disease. Int J Pharm 415:273\u2013283","journal-title":"Int J Pharm"},{"key":"2638_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2013.11.001","volume":"174","author":"S Papa","year":"2014","unstructured":"Papa S, Ferrari R, De Paola M, Rossi F, Mariani A, Caron I, Sammali E, Peviani M, Dell'Oro V, Colombo C, Morbidelli M, Forloni G, Perale G, Moscatelli D, Veglianese P (2014) Polymeric nanoparticle system to target activated microglia\/macrophages in spinalcord injury. J Cont Rel 174:15\u201326","journal-title":"J Cont Rel"},{"key":"2638_CR141","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2217\/nnm.13.115","volume":"9","author":"NL Klyachko","year":"2013","unstructured":"Klyachko NL, Haney MJ, Zhao Y (2013) Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine 9:1403\u20131422","journal-title":"Nanomedicine"},{"key":"2638_CR142","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2013.09.006","volume":"66","author":"Y Cheng","year":"2014","unstructured":"Cheng Y, Morshed RA, Auffinger B, Tobias AL, Lesniak MS (2014) Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev 66:42\u201357","journal-title":"Adv Drug Deliv Rev"},{"key":"2638_CR143","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Cont Rel 161:505\u2013522","journal-title":"J Cont Rel"},{"key":"2638_CR144","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","volume":"190","author":"H Cabral","year":"2014","unstructured":"Cabral H, Kataoka K (2014) Progress of drug-loaded polymeric micelles into clinical studies. J Cont Rel 190:465\u2013476","journal-title":"J Cont Rel"},{"key":"2638_CR145","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H (2011) Aptamer-functionalized PEG\u2013PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32:8010\u20138020","journal-title":"Biomaterials"},{"key":"2638_CR146","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1021\/ac404050t","volume":"86","author":"CB Jacobs","year":"2014","unstructured":"Jacobs CB, Ivanov IN, Nguyen MD, Zestos AG, Venton BJ (2014) High temporal resolution measurements of dopamine with carbon nanotube yarn microelectrodes. Anal Chem 86:5721\u20135727","journal-title":"Anal Chem"},{"key":"2638_CR147","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nnano.2010.281","volume":"6","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Park J, Yoon OJ, Kim HW, Lee DY, Kim DH, Lee WB, Lee NE, Bonventre JV, Kim SS (2011) Amine-modified singlewalled carbon nanotubes protect neurons from injury in a rat stroke model. Nature Nanotechnol 6:121\u2013125","journal-title":"Nature Nanotechnol"},{"key":"2638_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.04.008","volume":"142","author":"S Das","year":"2016","unstructured":"Das S, Carnicer-Lombarte A, Fawcett JW, Bora U (2016) Bio-inspired nano tools for neuroscience. Prog Neurobiol 142:1\u201322","journal-title":"Prog Neurobiol"},{"key":"2638_CR149","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12951-017-0264-7","volume":"15","author":"A Da Silva-Candal","year":"2017","unstructured":"Da Silva-Candal A, Argibay B, Iglesias-Rey R, Vargas Z, Vieites-Prado A, L\u00f3pez-Arias E, Rodr\u00edguez-Castro E, L\u00f3pez-Dequidt I, Rodr\u00edguez-Y\u00e1\u00f1ez M, Pi\u00f1eiro Y, Sobrino T, Campos F, Rivas J, Castillo J (2017) Vectorized nanodelivery systems for ischemic stroke: a concept and a need. J Nanobiotechnol 15:30","journal-title":"J Nanobiotechnol"},{"key":"2638_CR150","doi-asserted-by":"publisher","first-page":"034018","DOI":"10.1117\/1.3147407","volume":"14","author":"M Pramanik","year":"2009","unstructured":"Pramanik M, Swierczewska M, Green D, Sitharaman B, Wang LV (2009) Single-walled carbon nanotubes as a multimodalthermoacoustic and photoacoustic-contrast agent. J Biomed Optic 14:034018","journal-title":"J Biomed Optic"},{"key":"2638_CR151","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1749-6632.1965.tb54077.x","volume":"119","author":"H Keberle","year":"1964","unstructured":"Keberle H (1964) The biochemistry of desferrioxamine and its relation to iron metabolism. Ann N Y Acad Sci 119:758\u2013768","journal-title":"Ann N Y Acad Sci"},{"key":"2638_CR152","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","volume":"26","author":"AI Bush","year":"2003","unstructured":"Bush AI (2003) The metallobiology of Alzheimer\u2019s disease. Trends Neurosci 26:207\u2013214","journal-title":"Trends Neurosci"},{"key":"2638_CR153","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-2006-102-303","volume":"10","author":"PA Adlard","year":"2006","unstructured":"Adlard PA, Bush AI (2006) Metals and Alzheimer\u2019s disease. J Alzheimers Dis 10:145\u2013163","journal-title":"J Alzheimers Dis"},{"key":"2638_CR154","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/nnm.09.29","volume":"4","author":"B Wilson","year":"2009","unstructured":"Wilson B (2009) Brain targeting PBCA nanoparticles and the blood-brain barrier. Nanomedicine 4:499\u2013502","journal-title":"Nanomedicine"},{"key":"2638_CR155","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jconrel.2015.03.024","volume":"206","author":"MA Lauzon","year":"2015","unstructured":"Lauzon MA, Daviau A, Marcos B, Faucheux N (2015) Nanoparticle mediated growth factor delivery systems: a new way to treat Alzheimer\u2019s disease. J Cont Rel 206:187\u2013205","journal-title":"J Cont Rel"},{"key":"2638_CR156","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijpharm.2005.09.040","volume":"314","author":"N Popovic","year":"2006","unstructured":"Popovic N, Brundin P (2006) Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm 314:120\u2013126","journal-title":"Int J Pharm"},{"key":"2638_CR157","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s11051-012-1316-4","volume":"14","author":"E Locatelli","year":"2012","unstructured":"Locatelli E, Franchini MC (2012) Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system. J Nanopart Res 14:1316","journal-title":"J Nanopart Res"},{"key":"2638_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","volume":"70","author":"KS Soppimath","year":"2001","unstructured":"Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Cont Rel 70:1\u201320","journal-title":"J Cont Rel"},{"key":"2638_CR159","first-page":"373","volume":"103","author":"MJ Pisani","year":"2009","unstructured":"Pisani MJ, Wheate NJ, Keene FR, Aldrich-Wright JR, Collins JG (2009) Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs. J Inorg Chem 103:373\u2013380","journal-title":"J Inorg Chem"},{"key":"2638_CR160","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2\u201314","journal-title":"Adv Drug Deliv Rev"},{"key":"2638_CR161","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2217\/nnm.12.86","volume":"7","author":"KK Jain","year":"2012","unstructured":"Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood\u2013brain barrier. Nanomedicine 7:1225\u20131233","journal-title":"Nanomedicine"},{"key":"2638_CR162","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3329\/ijpls.v2i3.15457","volume":"2","author":"B Neha","year":"2013","unstructured":"Neha B, Ganesh B, Preeti K (2013) Drug delivery to the brain using polymeric nanoparticles: a review. Int J Pharm Life Sci 2:107\u2013132","journal-title":"Int J Pharm Life Sci"},{"key":"2638_CR163","volume-title":"Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications","author":"K Lee","year":"2016","unstructured":"Lee K, Solanki A, Kim JD, Jung J (2016) Nanomedicine: dynamic integration of nanotechnology with biomedical sciences; chapter II and Ellis-Behnke R, A small introduction to the world of nanomedicine; chapter III; and Allhoff R, The coming era of nanomedicine, chapter V. In: Bawa R, Audette GF, Rubinstein I (eds) Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications. Pan Standford Publishing, Singapore"},{"key":"2638_CR164","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1517\/17425247.2011.561311","volume":"8","author":"A Di Stefano","year":"2011","unstructured":"Di Stefano A, Iannitelli A, Laserra S, Sozio P (2011) Drug delivery strategies for Alzheimer\u2019s disease treatment. Expert Opin Drug Deliv 8:581\u2013603","journal-title":"Expert Opin Drug Deliv"},{"key":"2638_CR165","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10611860903112842","volume":"17","author":"KB Kurakhmaeva","year":"2009","unstructured":"Kurakhmaeva KB, Djindjikhashvili IA, Petrov VE, Balabanyan VU, Voronina TA, Trofimov SS, Kreuter J, Gelperina S, Begley D, Alyautdin RN (2009) Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 17:564\u2013574","journal-title":"J Drug Target"},{"key":"2638_CR166","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey WH (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481\u2013496","journal-title":"Neuroscience"},{"key":"2638_CR167","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","volume":"461","author":"C Zhang","year":"2014","unstructured":"Zhang C, Chen J, Feng C, Shao X, Liu Q, Zhang Q, Pang Z, Jiang X (2014a) Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease. Int J Pharm 461:192\u2013202","journal-title":"Int J Pharm"},{"key":"2638_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2014.11.012","volume":"90","author":"P Sozio","year":"2014","unstructured":"Sozio P, Fiorito J, Di Giacomo V, Di Stefano A, Marinelli L, Cacciatore I, Cataldi A, Pacella S, Turkez H, Parenti C, Rescifina A, Marrazzo A (2014) Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells. Eur J Med Chem 90:1\u20139","journal-title":"Eur J Med Chem"},{"key":"2638_CR169","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","volume":"87","author":"L Gastaldi","year":"2014","unstructured":"Gastaldi L, Battaglia L, Peira E, Chirio D, Muntoni E, Solazzi I, Gallarate M, Dosio F (2014) Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. Eur J Pharm Biopharm 87:433\u2013444","journal-title":"Eur J Pharm Biopharm"},{"key":"2638_CR170","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505\u2013515","journal-title":"Mol Pharm"},{"key":"2638_CR171","first-page":"63","volume":"5","author":"S Nelluri","year":"2015","unstructured":"Nelluri S, Felix JV, Sathesh KS (2015) Formulation and evaluation of galantamine nanoparticles for neurological disorders. Int J Pharm Chem Biol Sci 5:63\u201370","journal-title":"Int J Pharm Chem Biol Sci"},{"key":"2638_CR172","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/10611860802228350","volume":"16","author":"G Gregoriadis","year":"2008","unstructured":"Gregoriadis G (2008) Liposome research in drug delivery: the early days. J Drug Targe 16:520\u2013524","journal-title":"J Drug Targe"},{"key":"2638_CR173","doi-asserted-by":"publisher","first-page":"469679","DOI":"10.1155\/2011\/469679","volume":"2011","author":"C Spuch","year":"2011","unstructured":"Spuch C, Navarro C (2011) Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer\u2019s disease and Parkinson\u2019s disease). J Drug Deliv 2011:469679","journal-title":"J Drug Deliv"},{"key":"2638_CR174","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","volume":"31","author":"M Gobbi","year":"2010","unstructured":"Gobbi M, Re F, Canovi M, Beeg M, Gregori M, Sesana S, Sonnino S, Brogioli D, Musicanti C, Gasco P, Salmona M, Masserini ME (2010) Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. Biomaterials 31:6519\u20136529","journal-title":"Biomaterials"},{"key":"2638_CR175","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbamem.2010.10.014","volume":"1808","author":"GP Eckert","year":"2011","unstructured":"Eckert GP, Chang S, Eckmann J, Copanaki E, Hagl S, Hener U, M\u00fcller WE, K\u00f6gel D (2011) Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing. Biochim Biophys Acta 1808:236\u2013243","journal-title":"Biochim Biophys Acta"},{"key":"2638_CR176","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bbrc.2010.02.046","volume":"393","author":"C Lasagna-Reevesa","year":"2010","unstructured":"Lasagna-Reevesa C, Gonzalez-Romeroa D, Barriaa MA, Olmedoc I, Closa A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C (2010) Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393:649\u2013655","journal-title":"Biochem Biophys Res Commun"},{"key":"2638_CR177","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.colsurfb.2007.12.006","volume":"63","author":"RC Triulzi","year":"2008","unstructured":"Triulzi RC, Dai Q, Zou J, Leblanc RM, Gu Q, Orbulescu J, Huo Q (2008) Photothermal ablation of amyloid aggregates by gold nanoparticles. Colloids Surf B Biointerf 63:200\u2013208","journal-title":"Colloids Surf B Biointerf"},{"key":"2638_CR178","first-page":"44","volume":"32","author":"NF Gamaleia","year":"2010","unstructured":"Gamaleia NF, Shishko ED, Dolinsky GA, Shcherbakov AB, Usatenko AV, Kholin VV (2010) Photodynamic activity of hematoporphyrin conjugates with gold nanoparticles. Experiments in vitro. Exp Oncol 32:44\u201347","journal-title":"Exp Oncol"},{"key":"2638_CR179","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1242\/jcs.02439","volume":"118","author":"AM Marzesco","year":"2005","unstructured":"Marzesco AM, Janich P, Wilsch-Br\u00e4uninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118:2849\u20132858","journal-title":"J Cell Sci"},{"key":"2638_CR180","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.23627","volume":"72","author":"C Verderio","year":"2012","unstructured":"Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, Maiorino C, Servida F, Vercelli A, Rocca M, Dalla Libera D, Martinelli V, Comi G, Martino G, Matteoli M, Furlan R (2012) Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol 72:610\u2013624","journal-title":"Ann Neurol"},{"key":"2638_CR181","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1021\/nl801891q","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang J, Atay T, Nurmikko AV (2009) Optical detection of brain cell activity using plasmonic gold nanoparticles. Nano Lett 9:519\u2013524","journal-title":"Nano Lett"},{"key":"2638_CR182","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.biomaterials.2006.12.016","volume":"28","author":"P Zhang","year":"2007","unstructured":"Zhang P, Chen L, Gu W, Xu Z, Gao Y, Li Y (2007) In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer\u2019s disease. Biomaterials 28:1882\u20131888","journal-title":"Biomaterials"},{"key":"2638_CR183","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/354056a0","volume":"354","author":"S Iijima","year":"1991","unstructured":"Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354:56\u201358","journal-title":"Nature"},{"key":"2638_CR184","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejphar.2015.01.030","volume":"750","author":"AK Kakkar","year":"2015","unstructured":"Kakkar AK, Dahiya N (2015) Management of Parkinson\u2019s disease: current and future pharmacotherapy. Eur J Pharmacol 750:74\u201381","journal-title":"Eur J Pharmacol"},{"key":"2638_CR185","doi-asserted-by":"publisher","first-page":"8501693","DOI":"10.1155\/2016\/8501693","volume":"2016","author":"J Folch","year":"2016","unstructured":"Folch J, Petrov D, Ettcheto M, Abad S, S\u00e1nchez-L\u00f3pez E, Garc\u00eda ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A (2016) Current research therapeutic strategies for Alzheimer\u2019s disease treatment. Neural Plasti 2016:8501693","journal-title":"Neural Plasti"},{"key":"2638_CR186","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000101885","volume":"4","author":"EB Malarkey","year":"2007","unstructured":"Malarkey EB, Parpura V (2007) Applications of carbon nanotubes in neurobiology. Neurodegener Dis 4:292\u2013299","journal-title":"Neurodegener Dis"},{"key":"2638_CR187","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.addr.2013.07.002","volume":"65","author":"A Fabbro","year":"2013","unstructured":"Fabbro A, Prato M, Ballerini L (2013) Carbon nanotubes in neuroregeneration and repair. Adv Drug Deliv Rev 65:2034\u20132044","journal-title":"Adv Drug Deliv Rev"},{"key":"2638_CR188","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1353-8020(00)00064-X","volume":"7","author":"LL Dugan","year":"2001","unstructured":"Dugan LL, Lovett EG, Quick KL, Lotharius J, Lin TT, O'Malley KL (2001) Fullerene-based antioxidants and neurodegenerative disorders. Parkinson Rel Disord 7:243\u2013246","journal-title":"Parkinson Rel Disord"},{"key":"2638_CR189","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1073\/pnas.94.17.9434","volume":"94","author":"LL Dugan","year":"1997","unstructured":"Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, Shen CK, Luh TY, Choi DW, Lin TS (1997) Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A 94:9434\u20139439","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2638_CR190","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tox.2008.01.005","volume":"246","author":"AA Tykhomyrov","year":"2008","unstructured":"Tykhomyrov AA, Nedzvetsky VS, Klochkov VK, Andrievsky GV (2008) Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology 246:158\u2013165","journal-title":"Toxicology"}],"container-title":["Nanoscale Research Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-018-2638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s11671-018-2638-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-018-2638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T03:31:01Z","timestamp":1720495861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-018-2638-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":190,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2638"],"URL":"https:\/\/doi.org\/10.1186\/s11671-018-2638-7","relation":{},"ISSN":["1931-7573","1556-276X"],"issn-type":[{"value":"1931-7573","type":"print"},{"value":"1556-276X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"231"}}